These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11266239)

  • 1. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
    Aubier M; Wettenger R; Gans SJ
    Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
    Worth H; Muir JF; Pieters WR
    Respiration; 2001; 68(5):517-26. PubMed ID: 11694816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
    Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J
    Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG; Millar AB; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
    Boulet LP; Cartier A; Ernst P; Larivée P; Laviolette M
    Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ; Stampone P; O'Connor BJ
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
    Ohbayashi H; Adachi M; Ichinose M; Ohta K; Kokubu F; Sano Y; Tamura G; Tohda Y; Hirata K; Yasuba H
    Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF; Buist AS
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ; Currie GP; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
    Ederle K;
    Eur Rev Med Pharmacol Sci; 2003; 7(2):45-55. PubMed ID: 12911119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A; Hall I; Spelman R
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
    Tatsis G; Kotsifas K; Filaditaki V; Makrantoni G; Boulia S
    J Int Med Res; 2007; 35(3):361-73. PubMed ID: 17593865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma.
    Terzano C; Ricci A; Burinschi V; Nekam K; Lahovsky J
    Respir Med; 2003 Feb; 97 Suppl B():S35-40. PubMed ID: 12593526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
    Magnussen H
    Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ; Warner J; Staab D; Wahn U; Le Bourgeois M; van Essen-Zandvliet EE; Arora S; Pedersen S;
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.